Safety And Efficacy Of Supracor Algorithm For The Correction Of Presbyopia In Hyperopic Patients.

To evaluate the safety and efficacy of Supracor algorithm using excimer laser ablation in hyperopic presbyopic patients.

Nour El Hayah Eye Hospital

The present study included a retrospective review of patients diagnosed with hyperopia and presbyopia who underwent Supracor excimer laser treatment in one eye for presbyopia correction completed at least 12 months follow-up. The mean age was 48.33 (range from 44 to 55 years). Patients underwent bilateral hyperopic ablation profile in addition to non dominant eye supracor profile using the Femto-second laser in creating the flap.

In this study, we evaluated 48 patients who underwent bilateral hyperopic correction and Supracor presbyopic Femto-LASIK in the non-dominant eye. The mean preoperative spherical equivalent was 2.38 D (1.5-3.5), and the presbyopic correction was +1.39 ± 0.61D. After 12 months, the mean MRSE was -0.51 ± 0.43 D, with a mean UDVA of 20/25 (0.13 logMAR) and 20/20 (0.01 logMAR). Three patients lost one line of BCDVA; none lost two. Mean corneal steepening was 1.33 D (3 mm) and 0.71 D (5 mm). Mean vertical coma increased from -0.05 to +0.11. All patients achieved J1 near vision. Halos and glare were significant in 12 patients but decreased postoperatively.

Supracor excimer laser algorithm presented is safe and effective for the treatment of presbyopia in hyperopes. Monolateral Supracor treatments yielded no alteration of binocular vision.